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ABSTRACT Members of the ABC-F subfamily of ATP-binding cassette proteins mediate resistance to a broad array of clinically
important antibiotic classes that target the ribosome of Gram-positive pathogens. The mechanism by which these proteins act
has been a subject of long-standing controversy, with two competing hypotheses each having gained considerable support: anti-
biotic efflux versus ribosomal protection. Here, we report on studies employing a combination of bacteriological and biochemi-
cal techniques to unravel the mechanism of resistance of these proteins, and provide several lines of evidence that together offer
clear support to the ribosomal protection hypothesis. Of particular note, we show that addition of purified ABC-F proteins to an
in vitro translation assay prompts dose-dependent rescue of translation, and demonstrate that such proteins are capable of dis-
placing antibiotic from the ribosome in vitro. To our knowledge, these experiments constitute the first direct evidence that
ABC-F proteins mediate antibiotic resistance through ribosomal protection.
IMPORTANCE Antimicrobial resistance ranks among the greatest threats currently facing human health. Elucidation of the
mechanisms by which microorganisms resist the effect of antibiotics is central to understanding the biology of this phenomenon
and has the potential to inform the development of new drugs capable of blocking or circumventing resistance. Members of the
ABC-F family, which include lsa(A),msr(A), optr(A), and vga(A), collectively yield resistance to a broader range of clinically sig-
nificant antibiotic classes than any other family of resistance determinants, although their mechanism of action has been contro-
versial since their discovery 25 years ago. Here we present the first direct evidence that proteins of the ABC-F family act to pro-
tect the bacterial ribosome from antibiotic-mediated inhibition.
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Antibiotic resistance undermines effective antibacterial che-motherapy and represents a major threat to global public
health (1, 2). A comprehensive response to this problem includes
gaining a detailed understanding of the mechanisms by which
antibiotic resistance is mediated, particularly since such informa-
tion could inform the development of novel antibacterial agents
able to overcome or circumvent extant resistance phenotypes.
While the majority of clinically important antibiotic resistance
mechanisms are by now well characterized (3), some key gaps in
our knowledge remain. One such gap concerns themechanism by
which ABC-F proteins mediate resistance to a broad array of clin-
ically important antibiotic classes that target protein synthesis in
Gram-positive pathogens.
ABC-F proteins are found across all three domains of life, and
comprise a single polypeptide containing two ATP-binding cas-
sette (ABC) domains separated by a linker of ~80 amino acids. In
contrast to canonical ABC transporters, the ABC portions of
ABC-F proteins are not fused to transmembrane domains
(TMDs), nor are they genetically associated with TMDs in oper-
ons (4). While it may be that some ABC-F proteins associate with
TMDs to mediate transport across membranes, it is nevertheless
apparent thatmembers of this family participate in biological pro-
cesses other than transport, including DNA repair, enzyme regu-
lation, and translational control (5). In Gram-positive bacteria, a
subgroup of the ABC-F proteinsmediates resistance to antibiotics
that exert their action on the ribosome. These proteins, referred to
here as antibiotic resistance (ARE) ABC-F proteins, are found in
both antibiotic-producing bacteria (e.g., the streptomycetes) and
in pathogenic bacteria that include the staphylococci, strepto-
cocci, and enterococci (4, 6) (Fig. 1). Collectively, the ARE ABC-F
family of proteinsmediates resistance to themajority of antibiotic
classes that bind to the 50S subunit of the ribosome, including the
ketolides (7), lincosamides (8, 9),macrolides (10), oxazolidinones
(11), phenicols (11), pleuromutilins (12), and streptogramins of
groups A (9, 13) and B (10) (Fig. 1). However, no single ARE
ABC-F determinant confers resistance to every listed class, and
three phenotypic resistance profiles are distinguished in clinical
isolates. Combined lincosamide and streptogramin A (and some-
times pleuromutilin) resistance, referred to as the LSA (or LSAP)
phenotype, is conferred by vga-, lsa-, and sal-type genes (9, 14, 15),
concurrent resistance to macrolides and group B streptogramins
(and sometimes ketolides) (MSB phenotype) by the msr-type de-
terminants (7, 10), and resistance to phenicols and oxazolidinones
by the recently identified optrA gene (11) (Fig. 1).
The mechanism by which the ARE ABC-F proteins mediate
antibiotic resistance has been a subject of long-standing contro-
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versy, with two competing hypotheses having each attracted con-
siderable support (4, 6, 10, 16–20). The efflux hypothesis posits
that ARE ABC-F proteins associate with as-yet-unidentified
TMDs to form a functional efflux complex capable of exporting
antibiotics out of the cell, while the ribosomal protection hypoth-
esis suggests that these resistance proteins act instead to reduce the
accessibility or affinity of the antibiotic binding sites on the 50S
subunit of the ribosome, thereby directly protecting the transla-
tional machinery from antibiotic-mediated inhibition (16). In
proposed support of the efflux hypothesis, previous work has re-
portedmembrane localization of Vga(A) in Staphylococcus epider-
midis (18, 21), and evidence has been obtained for interaction
between the streptococcal ARE ABC-F protein Msr(D) and the
major facilitator protein Mef(E) when both are heterologously
expressed in Escherichia coli (19). Furthermore, studies showing
that staphylococci expressingAREABC-F resistance determinants
exhibit decreased accumulation of antibiotic classes that fall
within their phenotypic resistance profile (8, 10, 16, 22, 23) have
been considered evidence of efflux. However, subsequent work
has refuted this interpretation, demonstrating that such uptake
studies are incapable of distinguishing drug efflux from ribosomal
protection as decreased accumulation of antibiotics will also result
from protection of ribosomes (16), which ordinarily act as an
intracellular “sink” to increase drug accumulation (24).
Direct evidence for the ribosomal protection hypothesis is sim-
ilarly lacking. However, the specificity of the ARE ABC-F resis-
tance mechanism for multiple, structurally unrelated classes of
protein synthesis inhibitors is easier to interpret in the context of
ribosomal protection, and several ABC proteins not involved in
antibiotic resistance have recently been shown to interact directly
with the ribosome or with ribosomally associated proteins (4, 25).
In order to clarify the mechanism of the ARE ABC-F proteins,
we have studied the action of members of this family using bacte-
riological and biochemical assays, and thereby provide the first
direct evidence for a resistance mechanism involving ribosomal
protection.
RESULTS
The antibiotic resistance phenotype conferred by ARE ABC-F
proteins is suggestive of ribosomal protection. In initial experi-
ments using staphylococci expressing vga(A), we sought prelimi-
nary support for a mechanism of resistance involving either ribo-
somal protection or efflux. Previous studies have noted a
correlation between the resistance phenotypes mediated by ARE
ABC-F proteins and the extent of overlap between binding sites of
protein synthesis inhibitors within the PTC and peptide exit tun-
nel of the 50S subunit (16, 17). A testable prediction is that, if
Vga(A) does indeedmediate resistance through ribosomal protec-
tion, this protein would likely offer cross-resistance to further
classes of structurally unrelated antibiotic that bind the ribosome
in close proximity to the group A streptogramins. To examine
this, we performed susceptibility determinations with Staphylo-
coccus aureus RN4220(pSEPSA5:vga(A)) using a panel of 50S-
targeted antibiotics (see Table S1 in the supplementalmaterial). In
line with published data, expression of vga(A) conferred reduced
susceptibility to virginiamycin M (64-fold), lincomycin (8-fold),
and retapamulin (4-fold) but had no impact on susceptibility to
erythromycin, florfenicol, or linezolid. However, we also detected
a 4-fold decrease in susceptibility to the 16-member macrolides
carbomycin A and leucomycin A1, structurally related antibiotics
whose binding site on the ribosome is predicted to partially over-
lap that of members of the group A streptogramins (26). To our
knowledge, this is the first report of a vga-typeAREABC-F protein
mediating any degree of macrolide resistance, and offers further
indirect support for a mechanism of resistance involving ribo-
somal protection.
A common feature of antibiotic resistancemechanisms involv-
ing efflux is that, when coresident in a bacterial cell with a deter-
minant conferring resistance to the same antibacterial agent
through protection of the drug target, a synergistic or additive
increase in resistance is observed. For example, S. aureus strains
expressing both the tetracycline ribosome protection protein
(RPP), Tet(M), and the tetracycline efflux pump, Tet(K), exhibit a
FIG 1 Phylogenetic tree and antibiotic resistance profiles of the ARE ABC-F proteins found in representative Gram-positive pathogens. The tree was generated
using the maximum likelihood method with the MEGA 6.0.6 software package (47). An overview of the antibiotic resistance phenotypes conferred by the
different subgroups of determinant is given at the right of the figure, denoted by colored boxes (although variations in individual resistance phenotypes within
each subgroup are not shown).
Sharkey et al.
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substantial enhancement of tetracycline resistance comparedwith
strains expressing only one of these resistance mechanisms (27).
In contrast, no such enhancement in antibiotic resistance may be
observed when two resistance determinants, both of which act at
the level of the drug target, coexist in a bacterial cell. For example,
in fusidic acid-resistant strains of S. aureus carrying both resis-
tance polymorphisms in the drug target (EF-G) and a horizontally
acquired fusidic acid resistance gene (fusB), the level of resistance
observed does not exceed that of the determinant that alone pro-
vides the greatest degree of resistance (28).We therefore reasoned
that failure of Vga(A) to exhibit an additive or synergistic effect
when coresident in S. aureus with a ribosomal protection mecha-
nism of streptogramin resistance would suggest that Vga(A) does
not mediate resistance by efflux. To test this, we created a strain
carrying both vga(A) and cfr, the latter of which encodes an rRNA
methyltransferase capable of methylating 23S rRNA at position 8
of adenine 2503 (E. coli numbering) and thereby protects ribo-
somes from inhibition by several antibiotic classes, including
those encompassed within the spectrum of resistance of Vga(A)
(29). Susceptibility to virginiamycinM, lincomycin, and linezolid
was determined for S. aureus RN4220 expressing Vga(A) alone or
Vga(A) and Cfr. As expected, expression of Vga(A) alone medi-
ated resistance to virginiamycin M and lincomycin, but not to
linezolid, while expression of Cfr alone gave resistance to all three
drugs (see Table S2 in the supplemental material). Coexpression
of both resistance determinants did not confer a further decrease
in susceptibility to any of the drugs beyond that exhibited by the
strain solely expressing Cfr, establishing that coexpression of the
two resistance proteins does not produce an additive or synergistic
effect (Table S2) and further reinforcing the idea that resistance is
more likely mediated through ribosomal protection than efflux.
Purified ARE ABC-F proteins mediate specific and dose-
dependent protection of staphylococcal translation from anti-
biotic inhibition in vitro. Since our bacteriological studies
pointed toward ribosomal protection as the likely mechanism of
resistance of ARE ABC-F proteins, we sought to directly test the
ability of these proteins to protect the translation apparatus from
antibiotic-mediated inhibition. We therefore overexpressed and
purified recombinant Vga(A) from E. coli for addition into an
S. aureus in vitro coupled transcription/translation (T/T) assay.
Addition of a C-terminal hexahistidine (6His) tag to Vga(A) has
previously been demonstrated not to perturb the ability of the
protein to mediate resistance in whole cells (21), and we therefore
expressed Vga(A) fused to this tag to facilitate purification by
immobilized-metal affinity chromatography (IMAC). Effective
purification of Vga(A) required removal of contaminating nucleic
acids (21), whichwas achieved by the addition of 2MNaCl during
IMAC and subsequent gel filtration purification steps.
Introduction of 4 M purified Vga(A) into T/T assays inhib-
ited with a90% inhibitory concentration (IC90) of virginiamy-
cinM resulted in substantial restoration of translation, with activ-
ity rising to ~60% of that of the untreated control (Fig. 2A). In
contrast, Vga(A) offered no protection against inhibition of trans-
lation by a structurally and mechanistically unrelated inhibitor of
protein synthesis (fusidic acid) (Fig. 2A). The ability to rescue
translation from virginiamycin M was a specific property of
Vga(A), since no protection against this antibiotic was observed
when the fusidic acid resistance protein FusB (28) was substituted
for Vga(A), and protection was also lost upon heat denaturation
of Vga(A) (Fig. 2A). Protection of translation from virginiamycin
FIG 2 Vga(A) protects an S. aureus-derived T/T assay from inhibition by
virginiamycin M. (A) Column 1 shows an uninhibited T/T assay with no ad-
dition of exogenous protein, whilst column 2 shows an uninhibited assay with
the addition of 4MVga(A). In columns 3 and 5, 4MVga(A) added to a T/T
assay mixture containing IC90 of virginiamycin M (VGM [column 3]) res-
cued protein synthesis. In columns 3, 4, and 8, addition of 4 M heat-
denatured (Denat.) Vga(A) (column 4) or 4Mfusidic acid resistance protein
FusB (column 8) failed to rescue protein synthesis from inhibition by virgin-
iamycinM (column 3). In columns 6 and 7, addition of 4MVga(A) to a T/T
assay mixture containing IC90 of fusidic acid (FA) did not rescue protein
synthesis. (B) Dose-dependent rescue of protein synthesis by Vga(A) from
inhibition with IC90 of virginiamycin M. Results are means from at least
three independent determinations, and error bars show standard deviations.
ABC-F Proteins in Antibiotic Resistance
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M by Vga(A) exhibited dose dependence in the concentration
range between ~1 and 4 MVga(A) (Fig. 2A).
To confirm that the ability to protect the translation apparatus
from antibiotic-mediated inhibition is not unique to Vga(A) but
is a property shared by other ARE ABC-F proteins, we also puri-
fied and tested the ability of a phylogenetically distant member of
this family, Lsa(A) (Fig. 1), to rescue translation. Lsa(A) was over-
expressed in E. coli with N-terminal His and SUMO tags to max-
imize protein solubility. Both tagswere cleaved following an initial
IMAC purification step, yielding untagged Lsa(A) with an addi-
tional N-terminal glycine residue, which was subsequently puri-
fied to homogeneity by gel filtration. Purified Lsa(A) was titrated
into T/T reaction mixtures inhibited with aIC90 of virginiamy-
cin (Fig. 3A) or lincomycin (Fig. 3B). As for Vga(A), rescue of
translation was concentration dependent up to ~4 to 6Mand at
the highest protein concentrations tested restored translation ac-
tivity to at least ~50% in each case (Fig. 3A and B).
Recapitulationof resistancephenotypes associatedwithARE
ABC-F proteins in an in vitro translation assay. To provide fur-
ther confirmation that the observed ability of ARE ABC-F pro-
teins to protect an in vitro translation assay from antibiotics re-
flects the activity of these proteins in whole cells and to further
explore the phenomenon of protection, we sought to recapitulate
in the T/T assay several phenotypes that have been associated with
these proteins in bacteria.
The Vga(A) protein is not functional in E. coli, failing to confer
any reduction in virginiamycinM susceptibility evenwhen detect-
ably overexpressed (21; data not shown). This result wasmirrored
in an in vitro T/T assay using E. coli S30 extract; addition of in-
creasing concentrations of Vga(A) (Fig. 4A) and Lsa(A) (data not
shown) to maximum of 4 M into T/T reactions inhibited with
IC90 of virginiamycin M produced no rescue of translation.
It has previously been demonstrated that substitution for glu-
tamine of the catalytic glutamate residue following the Walker B
motif in either nucleotide binding domain of Vga(A) results in a
nonfunctional protein incapable ofmediating resistance to virgin-
iamycin M in cells of Staphylococcus epidermidis (21). We con-
firmed that this also holds true in cells of S. aureus, with expression
of Vga(A)E105Q in S. aureus RN4220 having no effect on virginia-
mycin M susceptibility (Fig. 4B). The same loss of the ability of
Vga(A)E105Q to mediate virginiamycin M resistance could also be
demonstrated in vitro, with addition of up to 4 M purified
Vga(A)E105Q to a T/T assay employing S. aureus S30 extract pro-
ducing no restoration of translation activity (Fig. 4B).
A single-amino-acid substitution (K219T) in the linker region
between the two nucleotide binding domains of Vga(A) has re-
cently been reported to increase the level of phenotypic resistance
to lincosamides from low level (4-fold) to high level (64-fold)
(20). This shift in resistance profile was successfully recapitulated
in the S. aureus T/T assay; addition of purified Vga(A)K219T to a
T/T reaction mixture inhibited with lincomycin resulted in resto-
ration of translation activity to ~30% of that of the uninhibited
control, while 4 M wild-type Vga(A) did not detectably protect
translation against lincomycin (Fig. 4C).
Lsa(A) prevents binding of antibiotic to staphylococcal ribo-
somes, and displaces ribosome-bound antibiotic.We sought to
examine whether the ARE ABC-F proteins protect the translation
apparatus from antibiotic-mediated inhibition by directly inter-
fering with the interaction between the antibiotic and the ribo-
some. In the first instance, we evaluated the ability of the Lsa(A)
protein to prevent binding of 3H-radiolabeled lincomycin to pu-
rified staphylococcal ribosomes. Preincubation of between 1:1
and 8:1 molar ratios of Lsa(A) to ribosomes prior to the addition
of [3H]lincomycin resulted in a dose-dependent decrease in sub-
sequent binding of lincomycin to ribosomes, before reaching a
plateau past which addition of Lsa(A) caused no further reduction
in lincomycin binding (Fig. 5A). In contrast, preincubation of
ribosomes with an 8-fold molar excess of an unrelated control
FIG 3 Lsa(A) mediates dose-dependent protection of a S. aureus-derived
transcription/translation assay from inhibition by virginiamycin M (A) and
lincomycin (B). Results are means from at least three independent determina-
tions, and error bars show standard deviations.
Sharkey et al.
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protein (bovine serum albumin [BSA]) did not reduce the level of
ribosomally associated [3H]lincomycin (Fig. 5B).
Subsequently, we examined the ability of Lsa(A) to displace
prebound [3H]lincomycin from ribosomes. We first confirmed
that this assay could demonstrate displacement of radiolabeled
lincomycin following addition of a 50-fold excess of the unlabeled
drug and that addition of an 8-fold molar excess of BSA had es-
sentially no effect on the level of ribosome-bound drug (Fig. 5C).
Addition of an 8-fold molar-excess of Lsa(A) to ribosomes prein-
cubated with a 2-fold molar-excess of drug resulted in a substan-
tial (~73%) reduction in ribosome-associated [3H]lincomycin
(Fig. 5C).
DISCUSSION
The ARE ABC-F proteins collectively yield resistance to a broader
range of clinically significant antibiotic classes than any other fam-
ily of resistance determinants. Despite their importance, the
mechanism by which they mediate antibiotic resistance has re-
mained obscure since their discovery 25 years ago (10). Here we
have provided several lines of indirect and direct evidence that
together reveal a mechanism of resistance involving ribosomal
protection. The demonstration that more than one member of
this family protects the staphylococcal translation apparatus from
antibiotic-mediated inhibition in vitro, under conditions where
transport cannot occur, coupledwith the lack of evidence for drug
efflux by the ARE ABC-F proteins, would appear to render the
efflux hypothesis redundant.
ARE ABC-F proteins rescue translation from antibiotic-
mediated inhibition by driving dissociation of bound antibiotic
molecules from the ribosome. The fact that a given ARE ABC-F
protein is capable of triggering dissociation of multiple structur-
ally distinct classes of antibiotic, provided these compounds share
overlapping binding sites, argues for a simplemechanism of resis-
tance based upon protein-mediated drug displacement. Such a
displacement mechanism underlies the only other clinically im-
FIG 4 Recapitulation of resistance phenotypes associated with ARE ABC-F proteins in vitro. (A) When expressed in E. coli, Vga(A) does not confer resistance
to virginiamycin M (21); addition of Vga(A) to an E. coli T/T assay containingIC90 of virginiamycin M (VGM) also failed to restore translational activity. (B)
ATPase activity is essential for Vga(A) function (21), and abrogation of ATPase activity of theN-terminal ABCdomain renderedVga(A) inactive when expressed
in S. aureus RN4220; the purified ATPase-deficient Vga(A)E105Q protein also failed to protect staphylococcal translation from inhibition by virginiamycin M in
vitro. (C) A single-amino-acid substitution in the interdomain linker expands the resistance spectrum of Vga(A) to encompass lincomycin (20). Addition of the
purified Vga(A)K219T to a staphylococcal T/T assay inhibited with aIC90 of lincomycin (LNC) restored translational activity, while addition of the wild-type
protein did not. Results are means from at least three independent determinations, and error bars show standard deviations.
ABC-F Proteins in Antibiotic Resistance
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portant example of antibiotic resistance involving ribosomal pro-
tection: resistance to tetracyclines mediated by RPPs. These pro-
teins, such as Tet(O) and Tet(M), reach into the tetracycline
binding site to directly dislodge the drug (30, 31).
While molecular detail regarding the interaction occurring be-
tween ARE ABC-F proteins and the ribosome will be contingent
on structural characterization of the complex they form, the re-
cent functional and structural characterization of a non-ARE, but
ribosome-binding, ABC-F protein offers a basis for informed
speculation. Energy-dependent translational throttle A (EttA) is a
bacterial ABC-F protein that binds the ribosome to regulate pro-
tein synthesis in response to changing cellular energy levels (32).
This protein binds into the E-site of the ribosome, bridging the L1
stalk and P-site, and modulates the conformation of the PTC
through contacts with ribosomal proteins, rRNA and P-site fMet-
tRNA (33). These interactions occur primarily through the EttA
interdomain linker, a well-conserved region of the protein desig-
nated the P-site tRNA interaction motif (32). In a recent paper,
Lenart et al. (20) noted that this motif is conserved in Vga(A),
although extended by an additional 30 amino acids, and demon-
strated that single-amino-acid substitutions within this additional
region can alter the resistance profile of Vga(A).On this basis, they
speculated that the Vga(A) linkermay act in an analogousmanner
to the EttA linker, but with the 30-amino-acid extension allowing
further penetration toward the PTC, where it causes dissociation
of its target drugs either directly, or through contacts with the
P-site tRNA (20). In light of the findings presented here, which
collectively confirm that the ARE ABC-F proteins do mediate re-
sistance at the ribosome—and indeed, that these proteins act to
displace bound antibiotic from the ribosome—such an explana-
tion for the mechanism of resistance appears compelling. How-
ever, it is of note that the interaction of EttA with the ribosomal
FIG 5 Lsa(A) prevents binding of lincomycin to staphylococcal ribosomes, and displaces ribosome-bound lincomycin. (A) Preincubation of increasing
concentrations of Lsa(A) with 0.5M staphylococcal ribosomes caused a reduction in binding of [3H]lincomycin. (B) Preincubation of 0.5M ribosomes with
a 50 excess of unlabeled lincomycin (LNC) decreased subsequent binding by [3H]lincomycin (column 2 versus 1). Preincubation with 4 M BSA did not
protect ribosomes from binding by [3H]lincomycin (columns 3 and 1). Addition of 4 M Lsa(A) resulted in decreased association of [3H]lincomycin with
ribosomes (column 4 versus 1). (C) Addition of a 50 excess of unlabeled lincomycin caused dissociation of [3H]lincomycin prebound to staphylococcal
ribosomes (column 2 versus 1), as did addition of 4 M Lsa(A) (column 4 versus 1); however, addition of BSA did not (column 3 versus 1). Results are means
from at least three independent determinations, and error bars show standard deviations.
Sharkey et al.
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L1-stalk is mediated by a second functionally important motif, a
44-amino-acid region between the Q-loop and signature motif of
the N-terminal ABC domain referred to as the arm region, which
is not present inAREABC-F proteins. This region is important for
determining the specificity of the protein-protein interactions in
which other ABC proteins participate (5, 34, 35). Therefore, while
the interdomain linker of AREABC-F proteinsmay interact with the
P-site tRNA ina similarmanner toEttA, the site andmodeofbinding
of the ARE ABC-F proteins to the ribosomemay be distinct.
MATERIALS AND METHODS
Bacteria and plasmids. The bacteria and plasmids used or generated in
this study are listed in Table 1.
Antibiotics, chemicals, and susceptibility testing. Antibiotics were
from Sigma (Poole, United Kingdom), with the exception of tylosin
(Cambridge Bioscience, Cambridge, United Kingdom), spiramycin
(Cambridge Bioscience), and sparsomycin (E. Cundliffe, University of
Leicester). Tritium (3H)-labeled lincomycin was synthesized by Quotient
Bio Research (Nottingham, United Kingdom).
MICs were determined by exposing bacteria to 2-fold serial dilutions
of antibacterial agents in Mueller-Hinton broth 2 (Oxoid, Cambridge,
United Kingdom) according to the guidelines provided by the CLSI (36).
ForMIC determinations using strains carrying antibiotic resistance genes
on expression plasmid pEPSA5, 1% (wt/vol) xylose was added to cultures
following their dilution to a 0.5McFarland standard to induce expression
from the pT5X promoter.
DNA manipulation. The oligonucleotide primers used for PCR are
listed in Table S3 in the supplemental material.
For expression in S. aureus, PCR amplicons corresponding to vga(A)
and lsa(A), and a synthesized DNA fragment corresponding to cfr (Gen-
Script, Piscataway, NJ), were ligated into the staphylococcal expression
vector pEPSA5 (37) and introduced into S. aureus RN4220 by electropo-
ration (38). In order to assess the activity of Vga(A) in the presence of the
cfr determinant, a strain of RN4220 was generated carrying vga(A) on the
chromosome and cfr on plasmid pSEPSA5:cfr. To achieve this, a PCR
amplicon of vga(A) downstream of the strong, constitutive promoter
Pcap1A (39) was ligated into the integrative vector pLL39 (40) and intro-
duced into S. aureus RN4220(pLL2787) (40) by electroporation, where-
TABLE 1 Bacteria and plasmids used in this study
Strain or plasmid Description Source or reference
Strains
E. faecalis ATCC 29212 Source of lsa(A) gene ATCC (48)
S. aureus RN4220 Restriction-deficient derivative of S. aureus 8325-4, used for routine cloning and
antibiotic susceptibility testing
49
E. coli
DH5 For routine cloning procedures Invitrogen, Paisley, United
Kingdom
BL21(DE3) Gold For expression of Vga(A) Agilent Technologies
BL21-CodonPlus(DE3) RIL For expression of Lsa(A) Agilent Technologies
CopyCutter EPI400 To maintain plasmid pSAluc at low copy number Epicenter, Madison, WI
S. aureus
RN4220 vga(A) S. aureus RN4220 with vga(A) integrated at 11 attB locus under control of
cap1a promoter
This study
RN4220 vga(A)(pEPSA5:cfr) S. aureus RN4220 vga(A), with cfr under control of pT5X promoter on pEPSA5 This study
RN4220(pEPSA5) RN4220 carrying pEPSA5 This study
RN4220(pEPSA5:cfr) RN4220 carrying cfr under control of pT5X promoter on pEPSA5 This study
RN4220(pEPSA5:vga(A)) RN4220 carrying vga(A) under control of pT5X promoter on pEPSA5 This study
Plasmids
pEPSA5 S. aureus/E. coli shuttle vector for expression of genes in S. aureus from xylose-
inducible promoter pT5X
37
pLL39 Single-copy integration vector for integration at L54a attB or 11 attB sites on
S. aureus chromosome
40
pLL2787 Accessory plasmid carrying 11 int gene 36
pIVEX2.3d:vga(A) For expression of Vga(A) with C-terminal 6His tag in E. coli 5 Prime GmbH, Düsseldorf,
Germany (21, 50)
pBEST Contains firefly luciferase (luc) gene under control of E. coli tac promoter Promega, Madison, WI
pSAluc Modified pBEST plasmid with luc gene under control of strong staphylococcal
cap1A promoter
44
pEPSA5:vgaA For expression of Vga(A) in S. aureus This study
pEPSA5:vgaE105Q For expression of ATPase-deficient mutant of Vga(A) in S. aureus This study
pEPSA5:vgaAK219T For expression of expanded-phenotype mutant of Vga(A) This study
pEPSA5:cfr For expression of cfr in S. aureus This study
pLL39:vga(A) For integration of vga(A) onto S. aureus chromosome under control of cap1a
promoter
This study
pIVEX2.3d:vga(A)E105Q For expression of ATPase-deficient mutant of Vga(A) with C-terminal 6His
tag in E. coli
This study
pIVEX2.3d:vga(A)K219T For expression of expanded-phenotype mutant of Vga(A) with C-terminal
6His tag in E. coli
This study
pET28a:SUMO-lsa(A) Modified pET28a expression vector encoding N-terminal 6His and SUMO
(type 3) tags followed by recognition site for U1p protease, used to express
Lsa(A)
This study
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upon it became integrated into the chromosome at the 11 attB site. A
construct for overexpression of Vga(A) with a C-terminal 6His tag in
E. coli was generated as previously described (21). The lsa(A) gene was
amplified from Enterococcus faecalis ATCC 29212 (NCBI WP_
002365053.1) and ligated into a modified pET28b plasmid (Merck
KGaA, Darmstadt, Germany) encoding N-terminal 6His and SUMO
tags (41). The resulting expression constructs were transformed into
E. coli BL21(DE3) Gold (Agilent Technologies, Cheshire, United King-
dom) and BL21-CodonPlus(DE3) RIL (Agilent Technologies), respec-
tively. Nucleotide replacements to encode amino acid substitutions E105Q
and K219T in Vga(A) were independently engineered into constructs car-
rying vga(A) using the QuikChange Lightning kit (Agilent Technologies).
Heterologous expression and purification of proteins. Vga(A) and
Lsa(A) were overexpressed in E. coli by autoinduction (42) at 25°C for
4 days, and cells were harvested by centrifugation. Cell pellets were resus-
pended at 3 ml/g in buffer A (50 mMNaH2PO4 [pH 8.0], 300 mMNaCl,
10 mM imidazole), incubated with 7,000 U chicken egg-white lysozyme
(Sigma), complete EDTA-free protease inhibitor tablets (Roche, Mann-
heim, Germany), and 17 U Basemuncher endonuclease/ml of suspension
(Expedeon, Harston, United Kingdom) for 30 min, and lysed by sonica-
tion. Lysates were clarified by centrifugation at 30,000  g for 30 min.
Cleared lysate was loaded onto a 25-ml free-flow gravity column (Gene-
Flow, Elmhurst, United Kingdom) packed with 5 ml Ni-nitrilotriacetic
acid (NTA) agarose (Expedeon), washed with buffer A containing 20mM
imidazole and 2MNaCl, eluted in buffer A containing 250mM imidazole
and 2 M NaCl, and dialyzed overnight into buffer B (20 mM HEPES
[pH 7.5], 2 MNaCl, 1 mM dithiothreitol [DTT]). The C-terminal 6His
tag of Vga(A) was not removed, but the N-terminal 6His and SUMO
tags were removed from Lsa(A) by digestion with SUMO protease (Ulp,
Thermo, Fisher Scientific,MA) during dialysis. Dialyzed protein was sub-
jected to gel filtration using a Superdex 200 (16/60) column (GE Health-
care, Buckinghamshire, United Kingdom) preequilibrated with buffer B.
Lsa(A) was then exchanged into buffer C (50 mMHEPES [pH 7.4]) con-
taining 300 mMNaCl on HiTrap desalting columns (GEHealthcare) and
stored at80°C. Vga(A) was exchanged into buffer C with 50 mM NaCl
and further purified using a resource S column by elution with a 500 mM
NaCl gradient. Finally, Vga(A) was also exchanged to buffer C containing
300 mM NaCl prior to storage at 80°C. SDS-PAGE and peptide mass
fingerprinting were used to detect and confirm the identity of purified
proteins, with the latter performed by the University of Leeds Mass Spec-
trometry Facility. The FusB protein was expressed and purified as de-
scribed previously (43).
In vitro transcription/translation assays. Staphylococcal S30 extract
was prepared from S. aureus RN4220 following the protocol of Murray et
al. (44), although the preincubation step was omitted. E. coli S30 extract
was from Promega (Madison,WI). For T/T assays, an optimized quantity
of S30 extract was added into a 25-l reactionmixture containing 0.1mM
amino acids (Promega), 10 l S30 premix (Promega), 1 g of DNA tem-
plate (pSAluc or pBESTluc for S. aureus and E. coli T/T reactions, respec-
tively), and antibiotics and purified protein as required. Reaction mix-
tures were incubated for 1 h at 37°C, and the level of transcription/
translation was quantified by monitoring the expression of luciferase
produced from pSAluc/pBESTluc by the addition of luciferase assay re-
agent (Promega) and measurement of luminescence.
Purificationof staphylococcal ribosomes anduse in antibiotic bind-
ing assays. Ribosomes were purified from S30 fractions of S. aureus
RN4220 using L-cysteine Sulfolink resin (Thermo Fisher Scientific,
Waltham, MA) and ultracentrifugation, as previously described (45). For
quantitation, ribosomes were separated on a denaturing agarose gel
alongside anRNA standard of known concentration and analyzed by two-
dimensional (2D) densitometry using AIDA software (Raytest, Strauben-
hardt, Germany).
The ability of Lsa(A) to prevent binding of radiolabeled lincomycin to
the ribosome was assessed essentially as previously described for
tetracycline-ribosome binding studies (46). Ribosomes (500 nM) were
preincubated in 50-l reaction mixtures with Lsa(A), BSA, or unlabeled
lincomycin (concentrations described in Results) in assay buffer (10 mM
Tris [pH 7.5], 60 mM KCl, 10 mMNH4Cl, 300 mMNaCl, 6 mMMgCl2,
0.1 mM ATP) at 37°C. After 10 min, 1 M [3H]lincomycin was added,
and the reaction mixtures were incubated for a further 10 min before
recovering ribosomes on 0.45-m-pore nitrocellulose filters and two
rounds of washing with 200 l of ice-cold wash buffer (50 mM Tris,
50 mM KCl, 20 mM MgOAc) to remove unbound [3H]lincomycin.
Ribosome-associated [3H]lincomycin was then quantified by scintillation
counting.
The ability of Lsa(A) to displace prebound lincomycin from ribo-
somes was investigated using the same assay conditions; however, ribo-
someswere preincubatedwith [3H]lincomycin for 10min at 37°C prior to
the addition of Lsa(A), BSA, or unlabeled lincomycin. Reaction mixtures
were then incubated for a further 10 min at 37°C, before proceeding to
ribosome recovery, washing, and quantitation of ribosome-bound
[3H]lincomycin as described above.
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